Clinical Trial: A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909421) titled 'A Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies' on Oct. 26.

Brief Summary: This is a randomized, evaluator-blinded, parallel group, comparator-controlled, multicenter study to evaluate the safety and effectiveness of GP0112 for cheek augmentation and correction of midface contour deficiencies.

Approximately 326 subjects will be randomized (1:1) to either treatment with GP0112 or Juvederm Voluma XC(also known as Juvederm Voluma with lidocaine).

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Cheek Wrinkles Midface Contour Deficien...